Öz

Objective: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects multiple organ systems and is characterized by periods of flare-ups and remission. In approximately 15-20% of SLE patients, clinical symptoms onset during childhood or adolescence and are defined as juvenile SLE (jSLE). Age at disease onset has been suggested to influence the clinical phenotype, severity of inflammatory activity, and overall disease course in jSLE. The aim of this study was to compare clinical features and disease course between prepubertal (<10 years) and pubertal (≥10 years) jSLE patients.

Materials and Methods: This retrospective, single-center, cross-sectional study was conducted on patients diagnosed with jSLE who were followed up at the pediatric rheumatology clinic between January 2015 and September  2025. Patients included in the study had been diagnosed with jSLE according to the 2012 Systemic Lupus International Collaborating Clinics classification criteria.

Results: A total of 54 patients with juvenile-onset SLE were included, of whom 88.9% were female. Patients were grouped according to age at diagnosis: prepubertal-onset jSLE (<10 years) included 9 patients (16.7%), and pubertal-onset jSLE (≥10 years) included 45 patients (83.3%). Fever and elevated C-reactive protein levels were significantly more common in jSLE with pre-pubertal onset, whereas mucocutaneous involvement was more prevalent in jSLE with pubertal onset. Renal, hematological, and neurological involvement, autoantibody profiles, and disease activity and damage index at diagnosis were similar across groups. At the last visit, disease activity was significantly lower in jSLE with pre-pubertal onset. No differences in treatment were observed between age groups.

Conclusion: In this cohort, prepubertal-onset jSLE tended to present with more prominent inflammatory features, whereas pubertal-onset jSLE more often showed mucocutaneous involvement. Despite these observed phenotypic differences, cumulative organ damage appeared similar between groups.

Anahtar Kelimeler: Age of onset, puberty, systemic lupus erythematosus

Kaynakça

  1. Charras A, Smith E, Hedrich CM. Systemic Lupus Erythematosus in Children and Young People. Curr Rheumatol Rep. 2021;23(3):20. https://doi.org/10.1007/s11926-021-00985-0.
  2. Robinson GA, Knight A, Tucker LB, Belot A, Isenberg DA, Ciurtin C. Insights into the pathogenesis of childhood-onset SLE in the past decade. Nat Rev Rheumatol. 2026;22(1):26-41. https://doi.org/10.1038/s41584-025-01321-x.
  3. Smith EMD, Lythgoe H, Midgley A, Beresford MW, Hedrich CM. Juvenile-onset systemic lupus erythematosus: Update on clinical presentation, pathophysiology and treatment options. Clin Immunol. 2019;209:108274. https://doi.org/10.1016/j.clim.2019.108274.
  4. Lythgoe H, Smith EMD, Killeen OG, et al. Prospective epidemiological study of juvenile-onset systemic lupus erythematosus in the UK and Republic of Ireland. Rheumatology (Oxford). 2022;61(10):4097-4106. https://doi.org/10.1093/rheumatology/keac064.
  5. Kavrul Kayaalp G, Esencan D, Guliyeva V, et al. Childhood-onset systemic lupus erythematosus: A descriptive and comparative study of clinical, laboratory, and treatment characteristics in two populations. Lupus. 2024;33(10):1130-1138. https://doi.org/10.1177/09612033241265975.
  6. Fonseca R, Aguiar F, Rodrigues M, Brito I. Clinical phenotype and outcome in lupus according to age: a comparison between juvenile and adult onset. Reumatol Clin (Engl Ed). 2018;14(3):160-163. https://doi.org/10.1016/j.reuma.2016.10.011.
  7. Nelson MC, Mosley C, Villacis-Nunez DS, Rouster-Stevens K, Thakral A. Impact of follow-up adherence on disease activity in childhood-onset systemic lupus erythematosus (cSLE). Lupus. 2023;32(6):799-803. https://doi.org/10.1177/09612033231173530.
  8. Alexander T, Hedrich CM. Systemic lupus erythematosus - Are children miniature adults? Clin Immunol. 2022;234:108907. https://doi.org/10.1016/j.clim.2021.108907.
  9. Wu D, Ye L, Zhang X, Yin M, Guo Y, Zhou J. Characteristics of steroid hormones in systemic lupus erythematosus revealed by GC/MS-based metabolic profiling. Front Endocrinol (Lausanne). 2023;14:1164679. https://doi.org/10.3389/fendo.2023.1164679.1
  10. Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis & Rheumatism. 2012;64(8):2677-86. https://doi.org/10.1002/art.34473.
  11. Weening JJ, D’Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney international. 2004;65(2):521-30. https://doi.org/10.1111/j.1523-1755.2004.00443.x.
  12. Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288-91.
  13. Gutiérrez-Suárez R, Ruperto N, Gastaldi R, et al. A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus. Arthritis Rheum. 2006;54(9):2989-96. https://doi.org/10.1002/art.22048.
  14. Organization WH. The adolescent health indicators recommended by the Global Action for Measurement of Adolescent Health: Guidance for monitoring adolescent health at country, regional and global levels: World Health Organization; 2024. (Accessed on 2026 Jan 26, 2026)
  15. Sahin S, Adrovic A, Barut K, et al. Juvenile systemic lupus erythematosus in Turkey: demographic, clinical and laboratory features with disease activity and outcome. Lupus. 2018;27(3):514-9. https://doi.org/10.1177/0961203317747717.
  16. Hanif M, Sarker C, Al-Abadi E, et al. Contributors to organ damage in childhood lupus: corticosteroid use and disease activity. Rheumatology. 2025;64(5):3028-38. https://doi.org/10.1093/rheumatology/keae592.
  17. Cunningham MA, Richard ML, Wirth JR, et al. Novel mechanism for estrogen receptor alpha modulation of murine lupus. Journal of autoimmunity. 2019;97:59-69. https://doi.org/10.1016/j.jaut.2018.10.011.
  18. Nusbaum JS, Mirza I, Shum J, et al. Sex differences in systemic lupus erythematosus: epidemiology, clinical considerations, and disease pathogenesis. Mayo Clin Proc. 2020;95(2):384-94. https://doi.org/10.1016/j.mayocp.2019.09.012.
  19. Pan L, Liu J, Liu C, Guo L, Punaro M, Yang S. Childhood-onset systemic lupus erythematosus: characteristics and the prospect of glucocorticoid pulse therapy. Front Immunol. 2023;14:1128754. https://doi.org/10.3389/fimmu.2023.1128754.
  20. Li S, Xue Y, Kuang W, et al. Age-related differences in clinical and laboratory characteristics of childhood-onset systemic lupus erythematosus: Pre-puberal-onset SLE is prone to delayed diagnosis. Lupus. 2023;32(14):1675-80. https://doi.org/10.1177/09612033231212522.
  21. Gomes RC, Silva MF, Kozu K, et al. Features of 847 Childhood‐Onset Systemic Lupus Erythematosus Patients in Three Age Groups at Diagnosis: A Brazilian Multicenter Study. Arthritis Care & Research. 2016;68(11):1736-41. https://doi.org/10.1002/acr.22881.
  22. Batu ED, Sener S, Atamyildiz Ucar S, et al. A diagnostic algorithm to evaluate elevated C-reactive protein levels in juvenile systemic lupus erythematosus. Biomarkers. 2025 ;30(5):380-5. https://doi.org/10.1080/1354750X.2025.2556159.
  23. Rianthavorn P, Prurapark P. Infections in hospitalized children with newly diagnosed systemic lupus erythematosus in underresourced areas. Lupus. 2020;29(11):1475-82. https://doi.org/10.1177/0961203320939164.
  24. Massias J, Smith E, Al-Abadi E, et al. Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups. Lupus. 2020;29(5):474-81. https://doi.org/10.1177/0961203320909156.
  25. Nelson MC, Chandrakasan S, Ponder L, et al. Clinical determinants of childhood onset Systemic Lupus Erythematosus among early and peri-adolescent age groups. (Basel). 2022;9(12):1865. https://doi.org/10.3390/children9121865.
  26. DeCoste C, Moaf P, Mohamed I, et al. Adolescent health care needs and relationship to disease in patients with childhood‐onset systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2024;76(6):841-849. https://doi.org/10.1002/acr.25297.
  27. Abdwani R, Abdalla E, Al-Zakwani I. Unique characteristics of prepubertal onset systemic lupus erythematosus. International journal of pediatrics. 2019;2019(1):9537065. https://doi.org/10.1155/2019/9537065.
  28. Hui-Yuen J, Imundo L, Avitabile C, Kahn P, Eichenfield A, Levy D. Early versus later onset childhood-onset systemic lupus erythematosus: clinical features, treatment and outcome. Lupus. 2011;20(9):952-9. https://doi.org/10.1177/0961203311403022.

Telif hakkı ve lisans

Telif hakkı © 2026 Yazar(lar). Açık erişimli bu makale, orijinal çalışmaya uygun şekilde atıfta bulunulması koşuluyla, herhangi bir ortamda veya formatta sınırsız kullanım, dağıtım ve çoğaltmaya izin veren Creative Commons Atıf Lisansı (CC BY) altında dağıtılmıştır.

Nasıl atıf yapılır

1.
Özçelik E, Erdem Torun Ş, Öztürk D, Yoğun SN, Uğur Es Y, Işıklar Ekici M, et al. Clinical characteristics of juvenile systemic lupus erythematosus: Prepubertal and pubertal onset. Turk J Pediatr Dis. 2026;Early View:1-5. https://doi.org/10.12956/TJPD.2025.1304